Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Inogen IncINGN · Entity 2083 | Chief Commercial Officer | February 27, 2026 | March 03, 2026 |
| VAPOTHERM INCVAPO · Entity 87270 | SVP & Chief Commercial Officer | January 02, 2023 | January 04, 2023 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Inogen Inc
Report date February 27, 2026 · Filed March 03, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 44,229 |
Ending reported balance
After 2026-03-01 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2026-03-01 · Exercise / conversion · Acquired 13,005 · Balance 50,251 Row 2 · 2026-03-01 · Tax withholding · Disposed 6,022 · Balance 44,229 F1: The reported shares were withheld to cover the Reporting Person's tax withholding liability in connection with a portion of a time-based restricted stock award that vested on March 1, 2026. |
| Restricted Stock UnitSEC Table II · derivative / convertible security | Direct | 20,000 |
Reported balance
After 2026-02-27 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-02-27 · Grant · Acquired 20,000 · Balance 20,000 F2: Each restricted stock unit represents a contingent right to receive one share of Inogen common stock. F3: Subject to the reporting person's continued service, 1/3rd of the restricted stock units shall vest on March 1, 2027 (the "2027 Vesting Commencement Date"), and 1/3rd of the restricted stock units shall vest every year thereafter on the same day of the year as the 2027 Vesting Commencement Date. |
| Restricted Stock UnitSEC Table II · derivative / convertible security | Direct | 26,010 |
Reported balance
After 2026-03-01 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2026-03-01 · Exercise / conversion · Acquired 13,005 · Balance 26,010 F2: Each restricted stock unit represents a contingent right to receive one share of Inogen common stock. F4: 1/3rd of the restricted stock units vested on March 1, 2026 (the "2026 Vesting Commencement Date"), and subject to the reporting person's continued service, 1/3rd of the restricted stock units shall vest every year thereafter on the same day of the year as the 2026 Vesting Commencement Date. |
Filing footnotes · ownership attribution and instrument terms
F1: The reported shares were withheld to cover the Reporting Person's tax withholding liability in connection with a portion of a time-based restricted stock award that vested on March 1, 2026.
F2: Each restricted stock unit represents a contingent right to receive one share of Inogen common stock.
F3: Subject to the reporting person's continued service, 1/3rd of the restricted stock units shall vest on March 1, 2027 (the "2027 Vesting Commencement Date"), and 1/3rd of the restricted stock units shall vest every year thereafter on the same day of the year as the 2027 Vesting Commencement Date.
F4: 1/3rd of the restricted stock units vested on March 1, 2026 (the "2026 Vesting Commencement Date"), and subject to the reporting person's continued service, 1/3rd of the restricted stock units shall vest every year thereafter on the same day of the year as the 2026 Vesting Commencement Date.
VAPOTHERM INC
Report date January 02, 2023 · Filed January 04, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 88,434 |
Reported balance
After 2023-01-02 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2023-01-02 · Grant · Acquired 5,320 · Balance 88,434 F1: Restricted stock unit award granted under the Vapotherm, Inc. Amended and Restated 2018 Equity Incentive Plan (the "2018 Equity Plan") and the Vapotherm, Inc. Amended and Restated 2019 French Qualifying Sub Plan (the "French Sub Plan") in lieu of an annual increase in the reporting person's 2023 base salary. The restricted stock unit award will vest in full on December 31, 2023, subject to the reporting person's continued service as an employee or other service provider to the Issuer through the vesting date. F2: Includes 58,553 shares that will be issued over time upon vesting and settlement of restricted stock unit awards. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $2.70 · Expires 2033-01-02 | Direct | 54,675 |
Reported balance
After 2023-01-02 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2023-01-02 · Grant · Acquired 54,675 · Balance 54,675 F3: This option was granted under the 2018 Equity Plan and the French Sub Plan and will vest as to 25% of the underlying shares on January 2, 2024, and thereafter, as to the remaining 75% of underlying shares, in 36 monthly installments, subject to the reporting person's continued service as an employee or other service provider to the Issuer through the vesting dates. |
Filing footnotes · ownership attribution and instrument terms
F1: Restricted stock unit award granted under the Vapotherm, Inc. Amended and Restated 2018 Equity Incentive Plan (the "2018 Equity Plan") and the Vapotherm, Inc. Amended and Restated 2019 French Qualifying Sub Plan (the "French Sub Plan") in lieu of an annual increase in the reporting person's 2023 base salary. The restricted stock unit award will vest in full on December 31, 2023, subject to the reporting person's continued service as an employee or other service provider to the Issuer through the vesting date.
F2: Includes 58,553 shares that will be issued over time upon vesting and settlement of restricted stock unit awards.
F3: This option was granted under the 2018 Equity Plan and the French Sub Plan and will vest as to 25% of the underlying shares on January 2, 2024, and thereafter, as to the remaining 75% of underlying shares, in 36 monthly installments, subject to the reporting person's continued service as an employee or other service provider to the Issuer through the vesting dates.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 20, 2020 Filed Oct 22, 2020 16:02 UTC | VAPOTHERM INC VAPO · Entity 87270 | Exercise / conversionCommon Stock | 2,000 | $3.78 | $7,560.00 |
DisclosureSEC source: 0001562180-20-006414 · primarydocument.xml · nonDerivative · entry 1 Ramade Gregoire · CIK 0001752887 · Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,114 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 21, 2020 Filed Sep 22, 2020 17:48 UTC | VAPOTHERM INC VAPO · Entity 87270 | Exercise / conversionOption to purchase Common Stock · Derivative | 2,000 | $0.00 Strike: $3.78 | $0.00 |
DisclosureSEC source: 0001562180-20-006074 · primarydocument.xml · derivative · entry 3 Ramade Gregoire · CIK 0001752887 · Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,458 Underlying: Common Stock · 2,000 shares Expires 2028-07-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This option is fully vested. Read SEC document |
| September 21, 2020 Filed Sep 22, 2020 17:48 UTC | VAPOTHERM INC VAPO · Entity 87270 | SaleCommon Stock | 2,000 | $27.74 | $55,480.00 |
DisclosureSEC source: 0001562180-20-006074 · primarydocument.xml · nonDerivative · entry 2 Ramade Gregoire · CIK 0001752887 · Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,114 F1 · kind: The shares were sold pursuant to a sales plan adopted by the Reporting Person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. Read SEC document |
| September 21, 2020 Filed Sep 22, 2020 17:48 UTC | VAPOTHERM INC VAPO · Entity 87270 | Exercise / conversionCommon Stock | 2,000 | $3.78 | $7,560.00 |
DisclosureSEC source: 0001562180-20-006074 · primarydocument.xml · nonDerivative · entry 1 Ramade Gregoire · CIK 0001752887 · Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,114 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 01, 2020 Filed Sep 3, 2020 16:02 UTC | VAPOTHERM INC VAPO · Entity 87270 | GrantCommon Stock | 2,400 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-20-005835 · primarydocument.xml · nonDerivative · entry 1 Ramade Gregoire · CIK 0001752887 · Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,114 F1 · shares: Represents restricted stock units ("RSUs") granted to the Reporting Person under the Issuer's equity incentive plan, in connection with the Reporting Person's promotion to Senior Vice President & Chief Commercial Officer. Each RSU represents the contingent right to receive one share of Common Stock. The RSUs vest 100% on the third anniversary of the date of grant, subject to the Reporting Person's continuous service to the Issuer through such vesting date. Read SEC document |
| August 20, 2020 Filed Aug 21, 2020 16:01 UTC | VAPOTHERM INC VAPO · Entity 87270 | Exercise / conversionOption to purchase Common Stock · Derivative | 2,000 | $0.00 Strike: $3.78 | $0.00 |
DisclosureSEC source: 0001562180-20-005607 · primarydocument.xml · derivative · entry 3 Ramade Gregoire · CIK 0001752887 · Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,458 Underlying: Common Stock · 2,000 shares Expires 2028-07-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This option is fully vested. Read SEC document |
| August 20, 2020 Filed Aug 21, 2020 16:01 UTC | VAPOTHERM INC VAPO · Entity 87270 | SaleCommon Stock | 2,000 | $29.65 | $59,300.00 |
DisclosureSEC source: 0001562180-20-005607 · primarydocument.xml · nonDerivative · entry 2 Ramade Gregoire · CIK 0001752887 · Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,714 F1 · kind: The shares were sold pursuant to a sales plan adopted by the Reporting Person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. Read SEC document |
| August 20, 2020 Filed Aug 21, 2020 16:01 UTC | VAPOTHERM INC VAPO · Entity 87270 | Exercise / conversionCommon Stock | 2,000 | $3.78 | $7,560.00 |
DisclosureSEC source: 0001562180-20-005607 · primarydocument.xml · nonDerivative · entry 1 Ramade Gregoire · CIK 0001752887 · Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,714 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 20, 2020 Filed Jul 21, 2020 16:20 UTC | VAPOTHERM INC VAPO · Entity 87270 | Exercise / conversionOption to purchase Common Stock · Derivative | 2,000 | $0.00 Strike: $3.78 | $0.00 |
DisclosureSEC source: 0001562180-20-005197 · primarydocument.xml · derivative · entry 3 Ramade Gregoire · CIK 0001752887 · Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,458 Underlying: Common Stock · 2,000 shares Expires 2028-07-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This option is fully vested. Read SEC document |
| July 20, 2020 Filed Jul 21, 2020 16:20 UTC | VAPOTHERM INC VAPO · Entity 87270 | SaleCommon Stock | 2,000 | $49.30 | $98,600.00 |
DisclosureSEC source: 0001562180-20-005197 · primarydocument.xml · nonDerivative · entry 2 Ramade Gregoire · CIK 0001752887 · Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,714 F1 · kind: The shares were sold pursuant to a sales plan adopted by the Reporting Person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. Read SEC document |
| July 20, 2020 Filed Jul 21, 2020 16:20 UTC | VAPOTHERM INC VAPO · Entity 87270 | Exercise / conversionCommon Stock | 2,000 | $3.78 | $7,560.00 |
DisclosureSEC source: 0001562180-20-005197 · primarydocument.xml · nonDerivative · entry 1 Ramade Gregoire · CIK 0001752887 · Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,714 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 22, 2020 Filed Jan 23, 2020 17:10 UTC | VAPOTHERM INC VAPO · Entity 87270 | GrantStock Options (Right to buy) · Derivative | 12,279 | $0.00 Strike: $17.15 | $0.00 |
DisclosureSEC source: 0001562180-20-000494 · primarydocument.xml · derivative · entry 1 Ramade Gregoire · CIK 0001752887 · Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,279 Underlying: Common Stock · 12,279 shares Expires 2029-01-11 F1 · derivative.exercise_date: This option is eligible to vest as to 25% of the underlying shares, the total number of which were determined at the Issuer's Compensation Committee meeting on January 22, 2020, on January 11, 2020, and thereafter, as to the remaining 75% of underlying shares, in 36 equal monthly installments, provided that the Reporting Person continues to serve as an employee or other service provider to the Issuer on each vesting date and otherwise subject to the Company's applicable equity incentive plan. Read SEC document |
| January 01, 2020 Filed Jan 2, 2020 21:00 UTC | VAPOTHERM INC VAPO · Entity 87270 | GrantStock Options (Right to buy) · Derivative | 32,700 | $0.00 Strike: $12.16 | $0.00 |
DisclosureSEC source: 0001562180-20-000054 · primarydocument.xml · derivative · entry 1 Ramade Gregoire · CIK 0001752887 · Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,700 Underlying: Common Stock · 32,700 shares Expires 2030-01-01 F1 · derivative.exercise_date: This option is eligible to vest as to 25% of the underlying shares on January 1, 2021, and thereafter, as to the remaining 75% of underlying shares, in 36 monthly installments, provided that the Reporting Person continues to serve as an employee or other service provider to the Issuer on each vesting date and otherwise subject to the Company's applicable equity incentive plan. Read SEC document |
| January 17, 2019 Filed Feb 19, 2019 21:10 UTC | VAPOTHERM INC VAPO · Entity 87270 | GrantOption to purchase Common Stock · Derivative | 15,197 | $0.00 Strike: $1.68 | $0.00 |
DisclosureSEC source: 0001562180-19-001073 · primarydocument.xml · derivative · entry 2 Ramade Gregoire · CIK 0001752887 · Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,197 Underlying: Common Stock · 15,197 shares Expires 2028-01-17 F1 · derivative.exercise_date: This option is eligible to vest as to 25% of the underlying shares on January 17, 2019 and thereafter, as to the remaining 75% of underlying shares, in 36 equal monthly installments. Subject to the terms of the Company's equity incentive plan. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.